Caution is to be exercised in prescribing PHENTERMINE® (phentermine hydrochloride) for patients with even mild hypertension.
Insulin requirements in diabetes mellitus may be altered in association with the use of PHENTERMINE® and the concomitant dietary regimen.
PHENTERMINE® may decrease the hypotensive effect of guanethidine.
The least amount feasible should be prescribed or dispensed at one time in order to minimize the possibility of overdosage.
Carcinogenesis, Mutagenesis, Impairment of Fertility: Studies have not been performed with PHENTERMINE® (phentermine hydrochloride) to determine the potential for carcinogenesis, mutagenesis or impairment of fertility.
Pregnancy Teratogenic Effects: Pregnancy Category C. Animal reproduction studies have not been conducted with PHENTERMINE®. It is also not known whether ADIPEX-P® can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. PHENTERMINE® should be given to a pregnant woman only if clearly needed.
Nursing Mothers:
Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Pediatric Use:
Safety and effectiveness in pediatric patients have not been established.
Buy the best selling phentermine package ever: